Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Xi-Nan Wu"'
Autor:
Yue-Meng Wan, Zhi-qiang Li, Qiong Zhou, Chang Liu, Men-Jie Wang, Hui-Xin Wu, Yun-Zhen Mu, Yue-Feng He, Yuan Zhang, Xi-Nan Wu, Yu-Hua Li, Zhi-Yuan Xu, Hua-Mei Wu, Ying Xu, Jin-Hui Yang, Xiao-Fang Wang
Publikováno v:
Stem Cell Research & Therapy, Vol 11, Iss 1, Pp 1-13 (2020)
Abstract Background Mesenchymal stem cells (MSCs) are a population of pluripotent cells that might be used for treatment of liver disease. However, the efficacy of MSCs for mice with alcoholic hepatitis (AH) and its underlying mechanism remains uncle
Externí odkaz:
https://doaj.org/article/a93fe4e5098046f2b275e19ed19ec6b5
Autor:
Yue-Meng Wan, Hua-Mei Wu, Yu-Hua Li, Zhi-Yuan Xu, Jin-Hui Yang, Chang Liu, Yue-Feng He, Men-Jie Wang, Xi-Nan Wu, Yuan Zhang
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Externí odkaz:
https://doaj.org/article/538d4b6a96044f02a39c5c1084f2bf77
Autor:
Yue-Meng Wan, Hua-Mei Wu, Yu-Hua Li, Zhi-Yuan Xu, Jin-Hui Yang, Chang Liu, Yue-Feng He, Men-Jie Wang, Xi-Nan Wu, Yuan Zhang
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Tumor necrosis factor (TNF)-α-stimulated protein 6 (TSG-6) is a secreted protein with diverse tissue protective and anti-inflammatory properties. We aimed to investigate its effects in treating mice with alcoholic hepatitis (AH) and the associated m
Externí odkaz:
https://doaj.org/article/71dd2764586a4f67b560fc2756618d93
Autor:
Yue-Meng Wan, Zhi-Qiang Li, Chang Liu, Yue-Feng He, Men-Jie Wang, Xi-Nan Wu, Yuan Zhang, Yu-Hua Li
Publikováno v:
PLoS ONE, Vol 15, Iss 2, p e0228889 (2020)
Mesenchymal stem cells (MSCs) are a population of pluripotent cells that have been tested for the treatment of many inflammatory diseases. It remains unclear whether MSCs were effective in treating mice with alcoholic hepatitis (AH) and its underlyin
Externí odkaz:
https://doaj.org/article/24946561a3fa4b48a0274b6c84010ff0
Autor:
Yue-Meng Wan MD, PhD, Yu-Hua Li MD, Zhi-Yuan Xu MD, Hua-Mei Wu MD, Ying Xu MD, Mei Yang MD, PhD, Xi-Nan Wu MD, PhD
Publikováno v:
Integrative Cancer Therapies, Vol 17 (2018)
Background: The outcome of patients with intermediate stage hepatocellular carcinoma (HCC) treated by transarterial chemoembolization (TACE) remains poor. Search for a more effective therapy is still necessary. Objective: This study aimed to investig
Externí odkaz:
https://doaj.org/article/3d9570c9ec4e4bff9c98e93872cb1ad5
Autor:
Yue-Meng Wan, Qiong Zhou, Yuan Zhang, Yun-Zheng Mu, Yue-Feng He, Chang Liu, Hui-Xin Wu, Ritika Rauniyar, Xi-Nan Wu, Zhi-qiang Li
Publikováno v:
Journal of Radiation Research
The objective of the study was to explore the effects of behavioral and cognitive development in rats after prenatal exposure to 1800 and 2400 MHz radiofrequency fields. Pregnant female rats were exposed to radiofrequency fields beginning on the 21st
Autor:
Yue-Meng Wan, Li, Zhi-Qiang, Zhou, Qiong, Liu, Chang, Men-Jie Wang, Wu, Hui-Xin, Mu, Yun-Zhen, He, Yue-Feng, Zhang, Yuan, Xi-Nan Wu, Li, Yu-Hua, Xu, Zhi-Yuan, Wu, Hua-Mei, Xu, Ying, Yang, Jin-Hui, Wang, Xiao-Fang
Additional file 1:. Supplementary materials. Mouse bone marrow-derived mesenchymal stem cells: isolation, culture, characterization and transfection; sample collection, storage and various assay.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52b328e6e16ee4f023b1bdf9a3cfc285
Publikováno v:
Academic Radiology. 25:925-934
Transjugular intrahepatic portosystemic shunt (TIPS) is an established method for portal hypertension. This study was to investigate the long-term safety, technical success, and patency of TIPS, and to determine the risk factors and clinical impacts
Publikováno v:
Academic radiology. 27(3)
Rationale and Objectives Transjugular intrahepatic portosystemic shunt (TIPS) and partial splenic embolization (PSE) were two interventional therapies effective for the management of variceal bleeding with cirrhosis. This study aimed to investigate t
Publikováno v:
Clinical and Translational Gastroenterology
BACKGROUND Acute-on-chronic liver failure (ACLF) can be caused by reactivation of chronic hepatitis B virus (HBV) infection (HBV-ACLF). It's unclear whether HBV genotypes affect the clinical and therapeutical outcomes of patients with HBV-ACLF. This